Therapeutic use of cannabinoids in age-related pain: Current evidence and clinical perspectives.
| Journal | Pharmacological research |
| Study Type | Clinical Study |
| Population | Human participants |
Chronic pain affects up to 85% of older adults, yet conventional analgesics carry significant risks in this population including falls, cognitive impairment, and polypharmacy interactions. This review examines cannabinoids as a potential therapeutic alternative that may address both pain and the underlying inflammatory processes driving chronic pain in aging.
This comprehensive review examines the therapeutic potential of cannabinoids for age-related chronic pain, focusing on the concept of ‘inflammaging’ – the persistent low-grade inflammation that characterizes aging and contributes to chronic pain states. The authors explore how dysregulated endocannabinoid signaling in older adults may contribute to sustained inflammation and impaired pain resolution. The review synthesizes current evidence on cannabinoid mechanisms in pain modulation and inflammation resolution, though it appears to be primarily a narrative review rather than a systematic analysis of clinical trial data.
“This review reinforces what I observe clinically – older patients often respond well to cannabinoids for chronic pain, particularly when conventional options have failed or caused intolerable side effects. The inflammaging framework provides a compelling biological rationale for why cannabinoids may be particularly suited for geriatric pain management.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
Why do older adults experience more chronic pain than younger individuals?
Aging leads to immunosenescence, which dysregulates the inflammatory response and impairs the body’s natural resolution mechanisms. This results in sustained production of pro-inflammatory mediators and chronic low-grade inflammation called “inflammaging,” which contributes to persistent pain states in conditions like osteoarthritis and neuropathies.
The endocannabinoid system plays a role in modulating inflammation and pain perception, making it a potential therapeutic target for chronic pain in elderly patients. This system may help address the underlying inflammatory processes that contribute to persistent pain states in aging individuals.
Common age-related painful conditions include osteoarthritis, neuropathies, and musculoskeletal degeneration. These conditions are often associated with chronic inflammation and dysregulated pain responses that persist beyond the initial tissue damage.
How does inflammaging differ from normal inflammatory responses?
Normal inflammation resolves once the noxious stimulus is removed, with gradual reduction in inflammatory mediators and pain. In contrast, inflammaging involves persistent, low-grade inflammation due to impaired resolution mechanisms, leading to sustained pro-inflammatory mediator production and chronic pain maintenance.
What makes cannabinoids potentially useful for treating pain in older adults specifically?
Cannabinoids may address the underlying inflammatory dysregulation characteristic of aging, rather than just masking pain symptoms. They could potentially help modulate the chronic inflammatory state and hyperalgesia that develops when normal pain resolution mechanisms become impaired in elderly patients.
